KRISTOPHER PATNUGOT: Open Payments
NPI 1649614470 · ROYAL OAK, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,197 in 64 payments from 11 companies in 2025. Trend: 2023 $990 · 2024 $1,212 · 2025 $1,197
Food & beverage: $1,197
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $290 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 17 | $281 |
| Orexo US, Inc. | 11 | $187 |
| Indivior Inc. | 6 | $135 |
| Braeburn Inc. | 4 | $92 |
| Lundbeck LLC | 3 | $76 |
| Axsome Therapeutics, Inc. | 2 | $53 |
| Exact Sciences Corporation | 1 | $32 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| Neos Therapeutics, LP | 1 | $15 |
Products named: CAPLYTA, Zubsolv, MAVYRET, SUBLOCADE, VRAYLAR, REXULTI, BRIXADI, Auvelity.
Industry payments across MI — which companies pay providers there.
